Headquartered in Lachen, CH, Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. With nearly 12,000 employees worldwide Octapharma supports the treatment of patients in 118 countries with products across three therapeutic areas: Immunotherapy, Hematology and Critical Care. The group has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany, and Sweden.